Loading…
Jfl Life Sciences (JFLLIFE)₹12.90+4.45%Pharmaceuticals
Jfl Life Sciences is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 13.0 against a peer median of 17.1, and ROCE of 18.0% against a peer median of 10.8%, and latest-quarter sales growth of −4.2% against a peer median of 41.1%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | 96 | 44.3 | 5.5 | 2.6 | 0.28 | 0.0 | 79 | 1 | 53.9 | 900.0 | vs JFLLIFE |
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | vs JFLLIFE |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | vs JFLLIFE |
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | vs JFLLIFE |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs JFLLIFE |
| Jfl Life Sciences | 85 | 13.0 | 18.0 | 15.0 | 0.47 | 0.0 | 131 | 6 | −4.2 | 48.6 | — |
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs JFLLIFE |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | vs JFLLIFE |
| Rekvina Labs | 81 | — | −333.3 | — | — | 0.0 | 1 | −0 | — | — | vs JFLLIFE |
| Samrat Pharmachem | 80 | — | −3.0 | −4.8 | 0.16 | 0.4 | 289 | −3 | 0.7 | — | vs JFLLIFE |
| Shelter Pharma | 76 | 8.3 | 20.4 | 15.1 | 0.01 | 0.8 | 73 | 9 | 49.8 | 22.2 | vs JFLLIFE |
| Peer median | 85 | 17.1 | 10.8 | 8.3 | 0.15 | 0.0 | 76 | 4 | 41.1 | 48.6 |
Listed companies closest to Jfl Life Sciences in Pharmaceuticals include Concord Drugs, Cian Healthcare, Vaishali Pharma, Mercury Laboratories, Amwill Health Care, Denis Chem Lab, Vilin Bio Med, Rekvina Labs.
Concord Drugs, with a market cap of ₹95.99 Cr.
Jfl Life Sciences trades at a P/E of 13.0; the median of its peer set is 17.1. A P/E above or below the median is a description, not a judgement on value.
Jfl Life Sciences' return on capital employed is 18.0%, above the peer median of 10.8%.